Anti-HCV drugs in the pipeline
- 1 December 2011
- journal article
- review article
- Published by Elsevier in Current Opinion in Virology
- Vol. 1 (6) , 607-616
Abstract
No abstract availableKeywords
This publication has 84 references indexed in Scilit:
- Domain 3 of NS5A Protein from the Hepatitis C Virus Has Intrinsic α-Helical Propensity and Is a Substrate of Cyclophilin AJournal of Biological Chemistry, 2011
- Efficient hepatitis C virus particle formation requires diacylglycerol acyltransferase-1Nature Medicine, 2010
- A genome-wide genetic screen for host factors required for hepatitis C virus propagationProceedings of the National Academy of Sciences, 2009
- The Isomerase Active Site of Cyclophilin A Is Critical for Hepatitis C Virus ReplicationJournal of Biological Chemistry, 2009
- Roles for endocytic trafficking and phosphatidylinositol 4-kinase III alpha in hepatitis C virus replicationProceedings of the National Academy of Sciences, 2009
- Hepatitis C Virus NS5A Protein Is a Substrate for the Peptidyl-prolyl cis/trans Isomerase Activity of Cyclophilins A and BJournal of Biological Chemistry, 2009
- A Functional Genomic Screen Identifies Cellular Cofactors of Hepatitis C Virus ReplicationCell Host & Microbe, 2009
- Cyclophilin B stimulates RNA synthesis by the HCV RNA dependent RNA polymeraseBiochemical Pharmacology, 2009
- Naturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatment-naïve patientsHepatology, 2008
- Position-Dependent Function for a Tandem MicroRNA miR-122-Binding Site Located in the Hepatitis C Virus RNA GenomeCell Host & Microbe, 2008